ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v15i5.1959ppharm-1664Research ArticleКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИCLINICAL RECOMMENDATIONSАтриовентрикулярная (предсердножелудочковая) блокада у детейAtrioventricular Block in Childrenhttps://orcid.org/0000-0001-8195-5682КовалёвИ. А.KovalevIgor A.

Ковалёв Игорь Александрович, доктор медицинских наук, профессор заведующий отделом детской кардиологии и аритмологии Обособленного структурного подразделения

125412, Москва, ул. Талдомская, д. 2

igor.kovalev64@mail.ruhttps://orcid.org/0000-0001-7119-316XБелозёровЮ. М.BelozerovYuri M.https://orcid.org/0000-0002-6662-3548СадыковаД. И.SadykovaDinara I.https://orcid.org/0000-0003-0501-405XСабироваД. Р.SabirovaDina R.https://orcid.org/0000-0001-7362-2685ЯковлеваЛ. В.YakovlevaLyudmila V.https://orcid.org/0000-0003-2701-1079ХабибрахмановаЗ. Р.KhabibrakhmanovaZulfiya R.https://orcid.org/0000-0002-4129-2877СакеринА. С.SakerinAndrey S.Научно-исследовательский клинический институт педиатрии имени академика Ю.Е. Вельтищева Российского национального исследовательского медицинского университета имени Н.И. ПироговаРоссияVeltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical UniversityRussian FederationКазанский государственный медицинский университетРоссияKazan State Medical UniversityRussian FederationБашкирский государственный медицинский университетРоссияBashkir State Medical UniversityRussian FederationГородская клиническая больница имени Е.О. МухинаРоссияMukhina City Clinical HospitalRussian Federation201824122018155365375Copyright © Ковалёв И.А., Белозёров Ю.М., Садыкова Д.И., Сабирова Д.Р., Яковлева Л.В., Хабибрахманова З.Р., Сакерин А.С., 20182018Ковалёв И.А., Белозёров Ю.М., Садыкова Д.И., Сабирова Д.Р., Яковлева Л.В., Хабибрахманова З.Р., Сакерин А.С.Kovalev I.A., Belozerov Y.M., Sadykova D.I., Sabirova D.R., Yakovleva L.V., Khabibrakhmanova Z.R., Sakerin A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/1664

Нарушения ритма и проводимости сердца занимают одно из ведущих мест в структуре сердечно-сосудистой патологии у детей. Атриовентрикулярная блокада представляет собой замедление или прекращение проведения импульсов со стороны предсердий на желудочки. Коллектив авторов представляет разработанные на основании принципов доказательной медицины клинические рекомендации, включающие все этапы диагностики и лечения детей с атриовентрикулярной блокадой. Использование рекомендаций в клинической практике позволит осуществлять выбор наилучшей стратегии в диагностике и лечении атриовентрикулярной блокады у конкретного пациента.

Rhythm and conduction disorders of the heart occupy one of the leading places in the structure of cardiovascular pathology in children. Atrioventricular block is the slowing down or loss of impulses from the atria to the ventricles. The team of authors presents clinical guidelines based on the principles of evidence-based medicine, including all stages of diagnosis and treatment of children with atrioventricular block. The use of guidelines in clinical practice will allow to choose the best strategy for the diagnosis and treatment of atrioventricular block for each individual patient.

нарушение ритма сердцаатриовентрикулярная блокададетиэлектрокардиостимуляторheart rhythm disorderatrioventricular blockchildrenpacemakerОтсутствуетNot specifiedReferencesАритмии сердца: механизмы, диагностика, лечение / Под ред. В.Дж. Мандела. Пер. с англ. Т.2. — М.: Медицина; 1996. — 206 с.Cardiac arrhythmias: their mechanisms, diagnosis, and management. Ed by WJ Mandel. Vol. 2. Transl. from English. Moscow: Meditsina; 1996. 206 p. (In Russ).Белозеров Ю.М. Детская кардиология. — М.: МЕДпрессинформ; 2004. — 525 c.Belozerov YuM. Detskaya cardiologiya. Moscow: MEDpress-inform; 2004. 525 p. (In Russ).Егоров Д.Ф., Адрианов А.В. Диагностика и лечение брадикардии у детей. — СПб.: Человек; 2008. — 320 с.Egorov DF, Adrianov AV. Diagnostika i lechenie bradikardii u detei. St. Petersburg: Chelovek; 2008. 320 p. (In Russ).Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology. 2008;47 Suppl 3:iii35–37. doi: 10.1093/rheumatology/ken153.Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology. 2008;47 Suppl 3:iii35–37. doi: 10.1093/rheumatology/ken153.Walsh EP, Saul JP, Triedman JK. Cardiac arrhythmias in children and young adults with congenital heart disease. 1st ed. Philadelphia, PA, USA: LWW; 2001. 528 p.Walsh EP, Saul JP, Triedman JK. Cardiac arrhythmias in children and young adults with congenital heart disease. 1st ed. Philadelphia, PA, USA: LWW; 2001. 528 p.Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337–1382. doi: 10.1093/europace/eut082.Brugada J, Blom N, Sarquella-Brugada G, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337–1382. doi: 10.1093/europace/eut082.Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss & Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. Vol. 1. 7th ed. Philadelphia, PA, USA: LWW; 2008. 760 p.Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss & Adams’ heart disease in infants, children, and adolescents: including the fetus and young adult. Vol. 1. 7th ed. Philadelphia, PA, USA: LWW; 2008. 760 p.Park MK. Park’s pediatric cardiology for practitioners. 6th ed. Philadelphia, PA: Mosby Elsevier; 2014. 688 p.Park MK. Park’s pediatric cardiology for practitioners. 6th ed. Philadelphia, PA: Mosby Elsevier; 2014. 688 p.European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070–1118. doi: 10.1093/europace/eut206.European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070–1118. doi: 10.1093/europace/eut206.Clancy RM, Kapur RP, Molad Y, et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage, fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004;50(1):173–182. doi: 10.1002/art.11430.Clancy RM, Kapur RP, Molad Y, et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage, fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004;50(1):173–182. doi: 10.1002/art.11430.Кошелева Н.М., Алекберова З.С. Неонатальная волчанка // Современная ревматология. — 2015. — Т.9. — №4 — С. 92–97. doi: 10.14412/1996-7012-2015-4-92-97.Kosheleva NM, Alekberova ZS. Neonatal lupus. Modern Rheumatology Journal. 2015;9(4):92–97. (In Russ). doi: 10.14412/1996-7012-2015-4-92-97.Bader RS, Hornberger LK, Huhta JC. The perinatal cardiology handbook. 1st ed. Mosby; 2008. 526 p.Bader RS, Hornberger LK, Huhta JC. The perinatal cardiology handbook. 1st ed. Mosby; 2008. 526 p.Zeigler VL, Gillette PG, editors. Practical management of pediatric cardiac arrhythmias. Hoboken, NJ, USA: Wiley-Blackwell; 2001. 416 p.Zeigler VL, Gillette PG, editors. Practical management of pediatric cardiac arrhythmias. Hoboken, NJ, USA: Wiley-Blackwell; 2001. 416 p.Brucato A, Jonson A, Friedmen D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus. 2003;12(6):427–435. doi: 10.1191/0961203303lu408oa.Brucato A, Jonson A, Friedmen D, et al. Proposal for a new definition of congenital complete atrioventricular block. Lupus. 2003;12(6):427–435. doi: 10.1191/0961203303lu408oa.Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/ AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2014;64(19):2039–2060. doi: 10.1016/j.jacc.2014.08.003.Campbell RM, Douglas PS, Eidem BW, et al. ACC/AAP/ AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE 2014 appropriate use criteria for initial transthoracic echocardiography in outpatient pediatric cardiology: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Academy of Pediatrics, American Heart Association, American Society of Echocardiography, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Pediatric Echocardiography. J Am Coll Cardiol. 2014;64(19):2039–2060. doi: 10.1016/j.jacc.2014.08.003.Rychik J, Ayres N, Cuneo B, et al. American society of echocardiography guidelines and standards for performance of fetal echocardiography. J Am Soc Echocardiogr. 2004;17(7):803–810. doi: 10.1016/j.echo.2004.04.011.Rychik J, Ayres N, Cuneo B, et al. American society of echocardiography guidelines and standards for performance of fetal echocardiography. J Am Soc Echocardiogr. 2004;17(7):803–810. doi: 10.1016/j.echo.2004.04.011.Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209. doi: 10.1186/ar1957.Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209. doi: 10.1186/ar1957.Ruffatti A, Milanesi O, Chiandetti L, et al. A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block? Lupus. 2012;21(6):666–671. doi: 10.1177/0961203311430969.Ruffatti A, Milanesi O, Chiandetti L, et al. A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block? Lupus. 2012;21(6):666–671. doi: 10.1177/0961203311430969.Saxena A, Izmirly PM, Mendez B, et al. Prevention and treatment in utero of autoimmune associated congenital heart block. Cardiol Rev. 2014;22(6):263–267. doi: 10.1097/CRD.0000000000000026.Saxena A, Izmirly PM, Mendez B, et al. Prevention and treatment in utero of autoimmune associated congenital heart block. Cardiol Rev. 2014;22(6):263–267. doi: 10.1097/CRD.0000000000000026.Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–1445. doi: 10.1093/eurheartj/ehi325.Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–1445. doi: 10.1093/eurheartj/ehi325.Zipes DP, Link MS, Ackerman MJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2412–2423. doi: 10.1016/j.jacc.2015.09.041Zipes DP, Link MS, Ackerman MJ, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2412–2423. doi: 10.1016/j.jacc.2015.09.041

The authors declare that there are no conflicts of interest present.